ko	pathway	ratio_in_study	ratio_in_pop	p_value
ko04510	Focal adhesion	28/189	240/7206	1.76037183936e-11
ko05100	Bacterial invasion of epithelial cells	15/189	99/7206	3.42816291004e-08
ko04810	Regulation of actin cytoskeleton	24/189	264/7206	8.16494209551e-08
ko04512	ECM-receptor interaction	13/189	79/7206	1.06671051191e-07
ko04974	Protein digestion and absorption	13/189	96/7206	1.10390252875e-06
ko05205	Proteoglycans in cancer	22/189	271/7206	2.05138936925e-06
ko04933	AGE-RAGE signaling pathway in diabetic complications	15/189	135/7206	2.1390063443e-06
ko04151	PI3K-Akt signaling pathway	27/189	390/7206	2.95304426955e-06
ko05146	Amoebiasis	12/189	99/7206	9.3993209077e-06
ko04670	Leukocyte transendothelial migration	14/189	151/7206	3.81541707195e-05
ko05132	Salmonella infection	11/189	98/7206	4.63031847579e-05
ko05131	Shigellosis	10/189	82/7206	5.03970247889e-05
ko04668	TNF signaling pathway	12/189	120/7206	6.62842872254e-05
ko05200	Pathways in cancer	28/189	492/7206	9.3661876868e-05
ko04390	Hippo signaling pathway	15/189	188/7206	0.00011471834522
ko05410	Hypertrophic cardiomyopathy (HCM)	10/189	100/7206	0.000271060165254
ko04530	Tight junction	16/189	228/7206	0.000302035358433
ko04666	Fc gamma R-mediated phagocytosis	11/189	122/7206	0.000335628006505
ko05224	Breast cancer	13/189	174/7206	0.000621522027973
ko05130	Pathogenic Escherichia coli infection	8/189	77/7206	0.000864438105103
ko04310	Wnt signaling pathway	13/189	181/7206	0.00090053819792
ko05166	HTLV-I infection	18/189	292/7206	0.000979972115982
ko05412	Arrhythmogenic right ventricular cardiomyopathy (ARVC)	8/189	79/7206	0.00102506124539
ko04611	Platelet activation	12/189	163/7206	0.00114226766404
ko05161	Hepatitis B	12/189	173/7206	0.00190461152654
ko04144	Endocytosis	19/189	342/7206	0.00248772768917
ko04210	Apoptosis	12/189	180/7206	0.00265513825168
ko04115	p53 signaling pathway	7/189	74/7206	0.00311908570601
ko04722	Neurotrophin signaling pathway	11/189	160/7206	0.00313030879467
ko04912	GnRH signaling pathway	9/189	122/7206	0.00462652651068
ko01522	Endocrine resistance	9/189	124/7206	0.00514738573552
ko04015	Rap1 signaling pathway	15/189	278/7206	0.00674084315339
ko05217	Basal cell carcinoma	6/189	68/7206	0.00854990869501
ko05414	Dilated cardiomyopathy	8/189	112/7206	0.00899009529511
ko00590	Arachidonic acid metabolism	5/189	52/7206	0.0112816696279
ko04550	Signaling pathways regulating pluripotency of stem cells	10/189	165/7206	0.0112961144004
ko04916	Melanogenesis	9/189	142/7206	0.0121341453341
ko05211	Renal cell carcinoma	7/189	96/7206	0.012778723894
ko04658	Th1 and Th2 cell differentiation	7/189	96/7206	0.012778723894
ko04660	T cell receptor signaling pathway	8/189	124/7206	0.0159834321
ko05145	Toxoplasmosis	8/189	126/7206	0.0174506918474
ko04014	Ras signaling pathway	14/189	279/7206	0.019287249155
ko04514	Cell adhesion molecules (CAMs)	8/189	130/7206	0.020672218474
ko05220	Chronic myeloid leukemia	6/189	85/7206	0.0237602382066
ko04380	Osteoclast differentiation	8/189	134/7206	0.0242962109272
ko05210	Colorectal cancer	6/189	86/7206	0.0250050579861
ko04640	Hematopoietic cell lineage	5/189	64/7206	0.0257699149441
ko05133	Pertussis	6/189	87/7206	0.026292748848
ko04218	Cellular senescence	10/189	177/7206	0.0263040640964
ko05323	Rheumatoid arthritis	6/189	89/7206	0.0289988298677
ko05222	Small cell lung cancer	6/189	89/7206	0.0289988298677
ko04010	MAPK signaling pathway	15/189	321/7206	0.0293856737376
ko04060	Cytokine-cytokine receptor interaction	10/189	191/7206	0.0342154156684
ko00512	Mucin type O-glycan biosynthesis	3/189	29/7206	0.0393553195799
ko05014	Amyotrophic lateral sclerosis (ALS)	5/189	74/7206	0.0442718472571
ko05140	Leishmaniasis	5/189	75/7206	0.0464670464112
ko05418	Fluid shear stress and atherosclerosis	9/189	173/7206	0.0474167839248